Risk factors affecting decreased libido among middle-aged to elderly men; nocturnal voiding is an independent risk factor of decreased libido

K Shigehara, Y Kato, M Iijima, S Kawaguchi… - Sexual …, 2021 - academic.oup.com
Introduction Decreased libido in middle-aged and elderly men is often difficult to treat, and
identifying the risk factors affecting decreased libido is important for the clinical management …

[HTML][HTML] Advances in nanoparticle delivery system for erectile dysfunction: An updated review

NP Masuku, JO Unuofin, SL Lebelo - Sexual Medicine, 2021 - Elsevier
Introduction The use of current available treatment for male erectile dysfunction (ED) has
some limitations that are related to efficacy and adverse effects. Nanotechnology has been …

Repurposing of sitagliptin-melittin optimized nanoformula against SARS-CoV-2; antiviral screening and molecular docking studies

MW Al-Rabia, NA Alhakamy, OAA Ahmed, K Eljaaly… - Pharmaceutics, 2021 - mdpi.com
The outbreak of the COVID-19 pandemic in China has become an urgent health and
economic challenge. The objective of the current work was to evaluate the efficacy of the …

Investigating the potential of transdermal delivery of Avanafil using vitamin E-TPGS based mixed micelles loaded films

AA Alamoudi, OAA Ahmed, KM El-Say - Pharmaceutics, 2021 - mdpi.com
To avoid the first-pass metabolism of avanafil (AVA) and its altered absorption in the
presence of food after oral administration, this study aimed to investigate the potential of …

Nanotechnology-based drug delivery platforms for erectile dysfunction: addressing efficacy, safety, and bioavailability concerns

VM Hari Priya, A Ganapathy A, MG Veeran… - Pharmaceutical …, 2024 - Taylor & Francis
Erectile dysfunction (ED), is a common and multidimensional sexual disorder, which
comprises changes among any of the processes of the erectile response such as organic …

Characteristics and analytical methods of novel PDE5 inhibitor avanafil: an update

A Shrivastava - Hacettepe University Journal of the Faculty of …, 2022 - dergipark.org.tr
Erectile dysfunction (ED) affects middle and older age and occurrence increasing with age
of men. PDE5 inhibitors are commonly used for the treatment of ED. The incidences of …

Incorporating sodium deoxycholate endorsed the buccal administration of avanafil to heighten the bioavailability and duration of action

KM El-Say, OD Al-Hejaili, HS El-Sawy… - Drug Delivery and …, 2023 - Springer
The highly effective phosphodiesterase type 5 inhibitor (avanafil; AVA) is routinely
prescribed to treat erectile dysfunction. The drug has poor oral bioavailability and undergoes …

[PDF][PDF] Repurposing of sitagliptin-melittin optimized nanoformula against sars-cov-2: Antiviral screening and molecular docking studies. Pharmaceutics. 2021; 13: 1–21

MW Al-Rabia, NA Alhakamy, OAA Ahmed, K Eljaaly… - 2021 - academia.edu
The outbreak of the COVID-19 pandemic in China has become an urgent health and
economic challenge. The objective of the current work was to evaluate the efficacy of the …

[PDF][PDF] SEXUAL MEDICINE

NP Masuku, JO Unuofin, SL Lebelo - 2021 - academia.edu
Introduction: The use of current available treatment for male erectile dysfunction (ED) has
some limitations that are related to efficacy and adverse effects. Nanotechnology has been …

Buccal formulation of avanafil with enhanced bioavailability and prolonged duration

OD Al-hejaili, M Khalid, TA Ahmed… - US Patent …, 2024 - Google Patents
A buccal tablet formulation has a polyvinylpyrrolidone K-90 as a solid dispersion polymer, a
hydroxypropyl methylcellulose as a mucoadhesive polymer, a sodium deoxycholate as …